There is a constantly evolving knowledgebase regarding the safety of MRI in pregnant patients, as well as the safety of gadolinium administration, given potential fetal risks. This review provides an overview of national and international recommendations for patient screening and safety by trimester, evaluates the most recent literature regarding administration of gadolinium in pregnant patients, and discusses technical requirements when imaging pregnant patients. A protocol for imaging pregnant patients is provided, and multiple common indications for MRI in pregnancy are discussed. Level of Evidence 5. Technical Efficacy Stage 5. J. Magn. Reson. Imaging 2019;49:621-631.
© 2019 International Society for Magnetic Resonance in Medicine.
The use of magnetic resonance imaging in the obstetric patient.J Obstet Gynaecol Can. 2014 Apr;36(4):349-63. doi: 10.1016/s1701-2163(15)30612-5. J Obstet Gynaecol Can. 2014. PMID: 24798674 Review. English, French.
MRI safety and devices: An update and expert consensus.J Magn Reson Imaging. 2020 Mar;51(3):657-674. doi: 10.1002/jmri.26909. Epub 2019 Sep 30. J Magn Reson Imaging. 2020. PMID: 31566852
MRI breast screening revisited.J Magn Reson Imaging. 2019 May;49(5):1212-1221. doi: 10.1002/jmri.26547. Epub 2019 Jan 28. J Magn Reson Imaging. 2019. PMID: 30693603
Gadolinium-based contrast agents: A comprehensive risk assessment.J Magn Reson Imaging. 2017 Aug;46(2):338-353. doi: 10.1002/jmri.25625. Epub 2017 Jan 13. J Magn Reson Imaging. 2017. PMID: 28083913 Review.
Obstetrical complications associated with abnormal maternal serum markers analytes.J Obstet Gynaecol Can. 2008 Oct;30(10):918-932. doi: 10.1016/S1701-2163(16)32973-5. J Obstet Gynaecol Can. 2008. PMID: 19038077 Review. English, French.